CMS doubles down on Medicare drug price negotiations
By Jakob Emerson for Becker’s Hospital Review on March 17, 2025 CMS will not change the Biden administration’s plan to negotiate prices
Read MoreBy Jakob Emerson for Becker’s Hospital Review on March 17, 2025 CMS will not change the Biden administration’s plan to negotiate prices
Read MoreBy Toni King for Counterpoint Media I have been told that Medicare does not cover drugs when you are in
Read More(By Sydney Lupkin for NPR) Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly through its website. “It’s
Read More(By Jon Hamilton for NPR) In 2020, Sue Bell became one of the first Alzheimer’s patients in the U.S. to
Read MoreAre you enrolled in a Medicare Advantage plan you’re not sure is right for you? You can make changes to
Read More(Source oig.hhs.gov) There has been a substantial increase in the use of certain diabetes drugs in recent years. Certain diabetes
Read More(By Naomi Diaz for Becker’s Hospital Review) Cleveland Clinic researchers are using artificial intelligence to identify existing FDA-approved drugs that
Read More(By Rylee Wilson for Becker’s Hospital Review) Payers are navigating through the second year of major Inflation Reduction Act changes.
Read MoreHumana, Inc., has reported $1.2 billion in 2024 profits, which included a $693 million fourth-quarter loss as the health insurer
Read More(By Rylee Wilson for Becker’s Hospital Review) Express Scripts, The Cigna Group’s pharmaceutical benefit manager, will implement new policies designed
Read More